Abstract:Key PointsCNS remyelination is the regenerative process by which myelin sheaths are restored to demyelinated axons. Unlike the poor regeneration that occurs following neuronal injury, remyelination can occur as a spontaneous and efficient process in experimental models and many clinical conditions.Although remyelination can occur in multiple sclerosis (MS; a widely occurring demyelinating disease), it often fails, leaving axons demyelinated and vulnerable to degeneration. Recent studies have revealed the importance of the myelin sheath for maintaining axonal integrity and hence the importance of promoting remyelination in diseases such as MS as an effective means of neuroprotection.Remyelination is mediated by a population of adult neural stem cells that are widely distributed throughout the CNS and that are commonly referred to as oligodendrocyte precursor cells (OPCs). These cells respond to demyelination by activation, proliferation, migration and finally differentiation into remyelinating oligodendrocytes; it is the last of these processes that is most likely to fail in MS and leave areas of demyelination containing oligodendrocyte-lineage cells that are unable to fully differentiate.Remyelination is governed by a complex interaction of environmental signals and cell-intrinsic mechanisms that are triggered by the inflammatory response to injury. This response therefore has a key role in initiating remyelination. The network of signals that is involved in remyelination shows high levels of redundancy.In theory, remyelination can be enhanced either by promoting endogenous remyelination or by transplanting myelinating cells. The first approach, which may have a pharmacological basis, is especially attractive for diseases such as MS in which remyelination occurs and will involve either the antagonism of negative regulatory pathways and/or the enhancement of positive regulatory pathways.Cell therapy (transplantation) approaches to remyelination are expected to be of particular benefit for genetic demyelinating diseases in which there is an inherent defect in the oligodendrocyte lineage. Recent studies have provided proof-of-principle that human cells can be used to remyelinate the entire CNS in laboratory animal models.

Senescent-like microglia limit remyelination through the senescence associated secretory phenotype

Microglia Impede Oligodendrocyte Generation in Aged Brain

Rejuvenation of Regeneration in the Aging Central Nervous System.

Ageing impairs the regenerative capacity of regulatory T cells in mouse central nervous system remyelination

Restoring Nuclear Entry of Sirtuin 2 in Oligodendrocyte Progenitor Cells Promotes Remyelination During Ageing

337 Cellular senescence contributes to inflammation and disease progression in an animal model of multiple sclerosis

Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system

Innate immune training restores pro-reparative myeloid functions to promote remyelination in the aged central nervous system

[Neuroscience] Remyelination in the Central Nervous System

Long‐term demyelination and aging‐associated changes in mice corpus callosum; evidence for the role of accelerated aging in remyelination failure in a mouse model of multiple sclerosis

Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration

Aging compromises oligodendrocyte precursor cell maturation and efficient remyelination in the monkey brain

M2 Microglia and Macrophages Drive Oligodendrocyte Differentiation During CNS Remyelination

Senolytic treatment depletes microglia and decreases severity of experimental autoimmune encephalomyelitis

Remyelination in the CNS: from biology to therapy

The aging mouse CNS is protected by an autophagy-dependent microglia population promoted by IL-34

Accelerated Remyelination During Inflammatory Demyelination Prevents Axonal Loss and Improves Functional Recovery

Loss of miR-145 promotes remyelination and functional recovery in a model of chronic central demyelination

Glial aging and its impact on central nervous system myelin regeneration

An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination

Myelin dystrophy impairs signal transmission and working memory in a multiscale model of the aging prefrontal cortex